A Clinical Study of Oral Ketoconazole Therapy in Superficial Fungal Diseases: Multicenter Trials / 대한피부과학회지
Korean Journal of Dermatology
;
: 263-272, 1984.
Article
in Korean
| WPRIM
| ID: wpr-210212
ABSTRACT
Ketoconazole is one of the broad-spectrum oral antimycotic agents recently developed from imidazole derivatives. Authors performed multicenter trials to evaluate the therapeutic effect of ketoconazole in superficial fungal diseases. One hundred and eighty-four patients with superficial fungaI diseases were included in this study during 7 months from April to October, 1983 Patiets were treated with oral administration of 200 mg of ketoconazole(Nizoral) once a day for 4 weeks.-countinue-
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Administration, Oral
/
Ketoconazole
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
1984
Type:
Article
Similar
MEDLINE
...
LILACS
LIS